---
$id: https://graph.org.ai/products/commodity/51112502
$type: Product
source: UNSPSC
code: "51112502"
title: "Atrimustine"
class: "51112500"
classTitle: "Alkylating agent nitrogen mustard compounds"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Atrimustine

**UNSPSC Code**: 51112502
**Class**: [Alkylating agent nitrogen mustard compounds](Alkylating agent nitrogen mustard compounds.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nitrogen mustard compound and immunosuppressant with the molecular formula C41H47Cl2NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XC0K09B7K4, chemically known as estradiol 3-benzoate 17-glycolate, 4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate but more generally known as atrimustine, which bears US NIH Compound Identifier 53181. European Medicines Agency schedules Atrimustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05605MIG. The term ATRIMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). ATRIMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule atrimustine under HS 29224995 and SITC 51465. As of Q4 2014, ATRIMUSTINE remains US FDA's Preferred Term for this commodity. Atrimustine bears US NLM identifiers UMLS ID C0105764 and NCI Concept Code C1348. SMILES: CLCCN(C1CCC(CCCC(=O)OCC(=O)OC2C3(C(C4C(CC3)C3C(CC4)CC(OC(=O)C4CCCCC4)CC3)CC2)C)CC1)CCCL.

